Rohto Pharmaceutical Co.,Ltd.

Tokyo Stock Exchange 4527.T

Rohto Pharmaceutical Co.,Ltd. Price to Earnings Ratio (P/E) on January 14, 2025: 19.04

Rohto Pharmaceutical Co.,Ltd. Price to Earnings Ratio (P/E) is 19.04 on January 14, 2025, a -23.26% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Rohto Pharmaceutical Co.,Ltd. 52-week high Price to Earnings Ratio (P/E) is 28.79 on September 27, 2024, which is 51.21% above the current Price to Earnings Ratio (P/E).
Rohto Pharmaceutical Co.,Ltd. 52-week low Price to Earnings Ratio (P/E) is 18.94 on May 29, 2024, which is -0.49% below the current Price to Earnings Ratio (P/E).
Rohto Pharmaceutical Co.,Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is 23.18.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Tokyo Stock Exchange: 4527.T

Rohto Pharmaceutical Co.,Ltd.

CEO	Mr. Yamada Kunio
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	1-8-1, Tatsumi-nishi
Employees	7,259
Sector	Consumer Discretionary
Industries Cosmetics Eyewear Pharmaceuticals

Description

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.

Key trends

Past 5 years